Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease
Abstract COVID 19 is known to cause immune dysregulation and vitamin D is a known immunomodulator. This study aims to objectively investigate the impact of Pulse D therapy in reducing the inflammatory markers of COVID-19. Consented COVID-19 patients with hypovitaminosis D were evaluated for inflamma...
Guardado en:
Autores principales: | Maheshwar Lakkireddy, Srikanth Goud Gadiga, R. D. Malathi, Madhu Latha Karra, I. S. S. V. Prasad Murthy Raju, Ragini, Sangeetha Chinapaka, K. S. S. Sai Baba, Manohar Kandakatla |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4691f6014ad24c99bd2097a961d42910 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease
por: Maheshwar Lakkireddy, et al.
Publicado: (2021) -
Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
por: Browning DJ, et al.
Publicado: (2018) -
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro J, et al.
Publicado: (2016) -
In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane
por: Manjunathan,Reji, et al.
Publicado: (2015) -
No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
por: Zheng Shaoping, et al.
Publicado: (2021)